Andreas Argyrides
Stock Analyst at Wedbush
(2.24)
# 1187
Out of 5,218 analysts
98
Total ratings
53.09%
Success rate
24.31%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Ascendis Pharma | Reiterates: Outperform | 181 181 | 130.25 | 38.96% | 9 | Nov 15, 2024 | |
Larimar Therapeutics | Initiates Coverage On: Outperform | 26 | 6.16 | 322.08% | 1 | Oct 16, 2024 | |
Benitec Biopharma | Initiates Coverage On: Outperform | 35 | 11.87 | 194.86% | 1 | Oct 16, 2024 | |
Regulus Therapeutics | Reiterates: Outperform | 7 7 | 1.58 | 343.04% | 1 | Aug 14, 2024 | |
Rani Therapeutics Hl... | Initiates Coverage On: Outperform | 17 | 1.65 | 930.3% | 4 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Perform | n/a | n/a | n/a | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 104 | 51.39 | 102.37% | 14 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 102 | 18.83 | 441.69% | 5 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 5 | 1.01 | 395.05% | 1 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 9 | 0.92 | 878.26% | 7 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 19 19 | 11.91 | 59.53% | 9 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 4 9 | 3.63 | 147.93% | 4 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 29 29 | 17.03 | 70.29% | 3 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 21 21 | 8.27 | 153.93% | 4 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 224 224 | 123.57 | 81.27% | 4 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 57 57 | 19.82 | 187.59% | 2 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 6 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 5 7 | 1.13 | 519.47% | 3 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 10 | 6.54 | 52.91% | 1 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 16 10 | 2.04 | 390.2% | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 73 70 | 66.03 | 6.01% | 6 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 53 42 | n/a | n/a | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Aug 8, 2022 |